JNJ vs PNTG · P/E 17, rev $49.37B vs P/E 40, rev $583.3M
Johnson & Johnson (JNJ) versus Pennant Group Inc (PNTG) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Pennant Group Inc (PNTG) is a medical care facilities company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported PNTG revenue for 2026-06-30 was $583.3M. Net income was $17.6M. PNTG currently screens at market cap $1.20B and trailing P/E 40.2.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. PNTG currently screens at market cap $1.20B and trailing P/E 40.2.
Not investment advice. Open the JNJ and PNTG stock pages for the full models.
Not investment advice.